NMTC: NeuroOne Medical Technologies Corporation Company Sales Revenue

The modernization of photolithography equipment ensured the stable production of neurosurgical electrodes, which triggered growth in the sales history of NeuroOne Medical Technologies. Unique patents for ultra-precise signals protect the business from the IT sector, although pressure from industry behemoths creates risks of distribution blockages. The current metric settled at 0.01, confirming the high liquidity and commercial success of NeuroOne Medical Technologies.

Revenue and Sales Volume: NeuroOne Medical Technologies Corporation (NMTC) for 07/04/2022 - 11/14/2026

Comprehensive metric breakdowns and analytics for NeuroOne Medical Technologies Corporation (NMTC)

- current price and projected stock value:

Share Price NeuroOne Medical Technologies Corp.|NMTC - Consensus Target

- market capitalization information:

Market Value NeuroOne Medical Technologies Corporation|NMTC - Total Company Value

- balance sheet net asset value indicators:

Accounting Value per Share NeuroOne Medical Technologies|NMTC - Book Capitalization|Market-to-Book Ratio n1mtc.com|NMTC - Company Total Assets

- company liabilities and liquidity data:

Debt to Equity Ratio NeuroOne Medical Technologies|NMTC - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient NeuroOne|NMTC - Company Aggregate Debts|Debt to Book Value NeuroOne Medical Technologies Corporation|NMTC - Company Long-Term Debts|Company Short-Term Debts NeuroOne Medical Technologies|Quick Liquidity n1mtc.com

- company profitability and valuation multiples indicators:

NMTC - Net Income|Expected Net Income NeuroOne Medical Technologies|NMTC - P/E Multiple|Projected Price to Earnings Ratio n1mtc.com|NMTC - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Multiple NeuroOne Medical Technologies Corporation|NMTC - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) NeuroOne Medical Technologies|NMTC - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months n1mtc.com|NMTC - Earnings per share growth in current year|Net earnings per share change forecast for next year NeuroOne Medical Technologies

- company sales and revenue statistics:

NMTC - Company Revenue|Company Future Sales Volume NeuroOne Medical Technologies Corp.|NMTC - P/S Multiple|Market Cap to Future Revenue Ratio NeuroOne Medical Technologies Corporation

Summary company analysis:NMTC NeuroOne Medical Technologies Corp.

When constructing a defensive portfolio, fundamental screening requires confirmation of cash flow stability. This indicator measures the volume of realized products, filtering out secondary risks and capturing trading turnover dynamics. For NeuroOne Medical Technologies (NMTC), the value of 0.01 confirms the business's isolation from macroeconomic downturns due to stable demand for medical technologies. By analyzing the company's sales volatility, an investor can assess the reliability of the operating model.

Key competitors